Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katja Kühbach
The Amyloid-Β Oligomer Count in Cerebrospinal Fluid Is a Biomarker for Alzheimer's Disease
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Related publications
Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
Biological Psychiatry
Biological Psychiatry
Why Is Amyloid-Β PET Requested After Performing Cerebrospinal Fluid Biomarkers?
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Amyloid-Β-Induced Amyloid-Β Secretion: A Possible Feed-Forward Mechanism in Alzheimer's Disease
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Alzheimer's Disease, Cerebrovascular Disease, and the Β-Amyloid Cascade
Canadian Journal of Neurological Sciences
Medicine
Neurology
Imaging and Cerebrospinal Fluid Biomarkers in the Search for Alzheimer's Disease Mechanisms
Neurodegenerative Diseases
Neurology
Elevated Cerebrospinal Fluid Pressure in Patients With Alzheimer's Disease
Cerebrospinal Fluid Research
Neuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-Β in Mild Cognitive Impairment
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Impaired Lipoprotein Receptor-Mediated Peripheral Binding of Plasma Amyloid-Β Is an Early Biomarker for Mild Cognitive Impairment Preceding Alzheimer's Disease
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease
JAMA Neurology
Neurology
